CancerIQ logo — We connect a broader population of patients and providers to...

CancerIQ

We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment.

Founded 2013 United States Chicago, United States 39 employees Convertible Note Total: $20.00M Health Care, Information Technology

General Information

Company Name CancerIQ
Founded Year 2013
Location United States Chicago, United States +1
Founders / Decision Makers
Team member
Employees 39
Industries Health Care, Information Technology
Funding Stage Convertible Note
Social

Get notified when CancerIQ moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CancerIQ

CancerIQ is a health tech startup founded in 2013 in the United States. The company's motto is "We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment." CancerIQ assists healthcare providers in utilizing genetic information to predict, preempt, and prevent diseases, beginning with cancer. By simplifying the identification of at-risk patients, offering genetic evaluations at the point of care, and devising customized cancer prevention plans, the company aids healthcare systems in staying ahead of this costly and emotionally devastating disease. With its recent Convertible Note investment on 10 November 2023 from Cleveland Avenue, CancerIQ is poised for rapid growth. The company has garnered praise for its market-leading product from patients, providers, and healthcare executives alike. CancerIQ provides an opportunity to work with a team of innovative, driven individuals passionate about making a substantial impact in cancer prevention. For those with a zeal for healthcare, joining CancerIQ represents a chance to contribute to a mission-driven company that is achieving significant strides in the industry.

Taxonomy: Precision Medicine, Genetic Information, Cancer Prevention, Healthcare IT, Oncology, Big Data Analytics, Genetic Testing, Risk Prediction, Patient Engagement

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
10 Nov 2023
Series B •••••• 5
Investor Investor Investor
•••• ••••
03 Mar 2022
Series A •••••• 3
Investor Investor Investor
14 Aug 2020
Venture Round •••••• 1
Investor
31 Jan 2019
Seed Round •••••• 1
Investor
14 Oct 2014

View All 7 Funding Rounds

CancerIQ Alternatives & Competitors

CancerIQ vs
Arkus AI
Arkus AI Sweden

Drive the future of Personalized Medicine with AI

Convertible Note
8 employees
AI, Health Care
CancerIQ vs
MyGeneTeam
MyGeneTeam United States

Connecting healthcare providers, organizations, patients and families with experts in the evolving f...

8 employees
Health Care
CancerIQ vs
Invitae
Invitae United States

As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to i...

Acquired
679 employees
Biotechnology, Health Care

FAQ About CancerIQ

We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment.
CancerIQ was founded in 2013.
CancerIQ is headquartered in Chicago, United States.
CancerIQ operates in the following industries: Health Care, Information Technology.
CancerIQ has approximately 39 employees.
CancerIQ has completed 7 funding rounds, raising a total of $20.00M. The latest funding stage is Convertible Note.
Top alternatives and competitors to CancerIQ include Arkus AI, MyGeneTeam, Invitae, InformedDNA, Pairnomix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CancerIQ and Arkus AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CancerIQ and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy